High throughput screening system for development of anti-cancer drugs inducing HER2 internalization

被引：0
|
作者：
Isa, Masayuki [1 ]
Asanuma, Daisuke [1 ]
Namiki, Shigeyuki [1 ]
Kumagai, Kazuo [2 ]
Kojima, Hirotatsu [2 ]
Okabe, Tajayoshi [2 ]
Nagano, Tetsuo [2 ]
Hirose, Kenzo [1 ]
机构：
[1] Univ Tokyo, Sch Med, Dept Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan
[2] Univ Tokyo, Sch Med, OCDD, Bunkyo Ku, Tokyo 1130033, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：232P / 232P
页数：1
相关论文
共 50 条
  • [41] An In Vivo C. elegans Model System for Screening EGFR-Inhibiting Anti-Cancer Drugs
    Bae, Young-Ki
    Sung, Jee Young
    Kim, Yong-Nyun
    Kim, Sunshin
    Hong, Kyeong Man
    Kim, Heung Tae
    Choi, Min Sung
    Kwon, Jae Young
    Shim, Jaegal
    PLOS ONE, 2012, 7 (09):
  • [42] Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2
    Wang, Bo-Wei
    Huang, Chih-Hao
    Liu, Liang-Chih
    Cheng, Fang-Ju
    Wei, Ya-Ling
    Lin, Yueh-Ming
    Wang, Yu-Fei
    Wei, Ching-Ting
    Chen, Yeh
    Chen, Yun-Ju
    Huang, Wei-Chien
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [43] High throughput analysis in HER2 positive locally advanced breast cancer: pCR and mutational status
    Paris, Ida
    Minucci, Angelo
    Generali, Daniele
    Nanni, Simona
    D'angelo, Tatiana
    Pavese, Francesco
    Fabi, Alessandra
    De Bonis, Maria
    Cannita, Katia
    Piermattei, Alessia
    Tiberi, Giordana
    Fuso, Paola
    Carbognin, Luisa
    Rotondaro, Silvia
    Nero, Camilla
    Giacomini, Flavia
    Pasciuto, Tina
    Marrazzo, Maria
    Giaco, Luciano
    Mule, Antonino
    Masetti, Riccardo
    Franceschini, Gianluca
    Garganese, Giorgia
    Giannarelli, Diana
    Scambia, Giovanni
    CANCER RESEARCH, 2024, 84 (09)
  • [44] Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs
    Mustacchi, Giorgio
    Generali, Daniele
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) : 405 - 408
  • [45] Development of a High-Throughput Three-Dimensional Invasion Assay for Anti-Cancer Drug Discovery
    Evensen, Nikki A.
    Li, Jian
    Yang, Jie
    Yu, Xiaojun
    Sampson, Nicole S.
    Zucker, Stanley
    Cao, Jian
    PLOS ONE, 2013, 8 (12):
  • [46] Dual targeting non-overlapping epitopes in HER2 domain IV substantially enhanced HER2/HER2 homodimers and HER2/EGFR heterodimers internalization leading to potent antitumor activity in HER2-positive human gastric cancer
    Wei, Ruicheng
    Zhang, Wenli
    Yang, Futang
    Li, Qianhao
    Wang, Qingyu
    Liu, Ningshu
    Zhu, Jun
    Shan, Yongqiang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [47] HER2 positive breast cancer: is there a preventive role of cardioprotective drugs?
    Martins De Carvalho, M.
    Pinto, R. A.
    Proenca, T.
    Costa, I.
    Torres, S.
    Resende, C. X.
    Grilo, P. D.
    Amador, A. F.
    Costa, C.
    Calvao, J.
    Sousa, C.
    Paiva, M.
    Macedo, F.
    Marques, C.
    Cabrita, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2872 - 2872
  • [48] Targeting HER2 expression in cancer: New drugs and new indications
    Vranic, Semir
    Beslija, Semir
    Gatalica, Zoran
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (01) : 1 - 4
  • [49] SCREENING SYSTEM FOR ANTI-CANCER SUBSTANCES BASED ON THERAPEUTIC INDEX
    BROCK, N
    SCHNEIDER, B
    BIOMETRICS, 1964, 20 (02) : 380 - &
  • [50] A SCREENING SYSTEM FOR ANTI-CANCER AGENTS BASED ON THERAPEUTIC INDEX
    BROCK, N
    SCHNEIDE.B
    BIOMETRICS, 1965, 21 (01) : 150 - &
12345